What are the recommendations for managing telogen effluvium, especially in women, considering potential underlying vitamin and mineral deficiencies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Telogen Effluvium in Women

Screen for vitamin D, ferritin, and zinc deficiencies in all women presenting with telogen effluvium, as these are the most commonly deficient micronutrients with non-trivial prevalence rates that justify routine laboratory evaluation. 1, 2

Laboratory Evaluation Priority

The following tests should be ordered based on evidence of deficiency prevalence:

  • Serum ferritin: Deficiency found in 46.5% of female TE patients, making this the most common abnormality 3
  • Serum zinc: Patients with TE have significantly lower zinc levels compared to controls, with increased odds of levels below 70 μg/dL (OR 4.65,95% CI 1.12-17.68) 1
  • 25(OH) Vitamin D: Mean levels significantly lower in TE patients (13.31 ± 5.8 ng/ml) versus controls (33.61 ± 8.16 ng/ml) 4
  • Hemoglobin and iron studies: Iron deficiency detected in 29.5% of TE patients 3
  • Vitamin B12: Deficiency found in only 5.8% of patients 3
  • Thyroid function tests (TSH, T3): Important particularly in adolescent and post-menopausal women 3

Treatment Approach Based on Laboratory Results

For Vitamin D Deficiency

Oral vitamin D supplementation shows significant improvement in TE patients. After 3 months of oral vitamin D therapy, mean serum levels increased from 13.31 ng/ml to 38.4 ng/ml with clinical improvement in both acute and chronic TE 4. Vitamin D may also have preventive value when used during acute illness 5.

For Zinc Deficiency

Zinc supplementation (100 mg zinc aspartate + 20 mg biotin daily) may achieve complete regrowth in 33.3% of treatment-resistant cases 6. However, zinc doses above 15 mg daily require copper monitoring to prevent copper deficiency-induced hair loss 7. The zinc:copper ratio should be maintained at 8-15:1, with monitoring every 6-12 months 7.

For Iron/Ferritin Deficiency

Iron supplementation is indicated when ferritin levels are low, though the association between iron deficiency and TE remains inconsistent across studies 1, 6. The evidence shows ferritin deficiency is common (46.5% of patients) but its causal role is debated 3. Iron supplementation should be separated from calcium supplements for optimal absorption 1.

Adjunctive Topical Therapy

Topical minoxidil applied twice daily is the primary evidence-based treatment for telogen effluvium 6. Individual response varies based on genetic factors and scalp sulfotransferase enzyme activity 6. Hypertrichosis occurs in approximately 15% of patients, which may limit acceptability 6.

Preventive Nutritional Strategies

Dietary supplements including vitamin C, vitamin D, lactoferrin, and zinc used during acute illness may have preventive value against post-illness telogen effluvium 5. Conversely, azithromycin and ivermectin may have negative long-term effects on hair shedding 5.

Scalp Care Recommendations

  • Use pH-neutral (pH 5) gentle shampoos 6
  • Apply hypoallergenic moisturizing creams once daily 6
  • Wash hair with tepid water only, avoiding hot water 6
  • Apply broad-spectrum sunscreen (SPF 30+) with zinc oxide or titanium dioxide to exposed scalp 6
  • Avoid greasy creams, occlusive products, topical acne medications, and hot blow-drying 6

Important Caveats

Ferritin interpretation in post-COVID TE requires caution. While ferritin levels are lower in TE patients compared to controls, they often remain above the cutoff for diagnosing non-anemic iron deficiency, making ferritin a poor biomarker in post-infectious TE cases 5. This is because ferritin also serves as an inflammatory marker during acute illness.

Not all TE cases have nutritional deficiencies. Recent evidence shows nutritional deficiencies are not as common as previously thought, with vitamin B12 deficiency found in only 5.8% and folic acid deficiency in only 0.6% of patients 3, 8. A detailed history focusing on physiological stress, surgical trauma, medications, and inflammatory/infectious triggers is essential before attributing TE solely to nutritional causes 8.

Related Questions

What vitamin and mineral deficiencies, and other lab investigations, should be studied in a patient, particularly a woman with a history of thyroid disorders, autoimmune diseases, or recent significant weight loss, presenting with telogen effluvium?
What supplements are recommended for a woman with a history of thyroid disorders, autoimmune diseases, or significant weight loss, presenting with telogen effluvium, and is biotin supplementation necessary?
What is the treatment for telogen effluvium?
What is the best approach to manage telogen effluvium in patients, including those with iron deficiency or hormonal imbalances, and considering various treatment options such as iron supplementation (ferrous sulfate), biotin supplements, low-level laser therapy (LLLT), and platelet-rich plasma (PRP) therapy?
What is the best treatment for telogen effluvium?
In an elderly female with significantly elevated alkaline phosphatase (ALP) levels suspected of having bone metastasis, where should we look for bone metastasis?
What is the role of antiplatelet therapy, such as aspirin, in primary cardiovascular prevention for high-risk individuals?
What is the management approach for a neonate who has experienced cardiac arrest and severe brain injury?
What is the difference between hydrochlorothiazide (HCTZ) and metolazone in treating a patient with hypertension or edema, particularly in those with normal vs impaired renal function?
What is the appropriate dosage of Zofran (ondansetron) for a 40 kg female patient experiencing vomiting?
What is the appropriate treatment approach for a patient with a partial right bundle branch block?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.